Previous 10 | Next 10 |
On August 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q2 2022. I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. June was a temporary bottom in the marke...
When investors are pessimistic about a stock, it's sometimes the optimists that end up coming out ahead. In that vein, DexCom 's (NASDAQ: DXCM) shares aren't performing up to their usual standard this year, with its stock price falling by 36% due to mediocre revenue growth and a reg...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund was down 18.60% (Institutional Shares) in the second quarter 2022. The economy is slowing, as we...
Baillie Gifford’s 13F portfolio value decreased from ~$143B to ~$97.51B this quarter. They increased Spotify and Royalty Pharma while decreasing Cloudflare, Petrobras, BeiGene, CBRE Group, Teladoc, and Peloton Interactive. The top three positions are Moderna, Tesla Motors, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senseonics (NYSEAMERICAN: SENS ) stock jumped by over 50% after it announced its Eversense implantable glucose monitor was approved for coverage by Elevance Health (NYSE: ELV ), formerly known as Anthem. Sense...
Earnings season always brings good news to some corporations and bad news to others. And the stakes are that much higher when equity indexes are down, and the world faces significant macroeconomic headwinds, including inflation. With that said, it's important to remember that quarterly ...
The simple and easy to use Dexcom ONE rt-CGM system is now listed on the NHS England, Wales, Scotland and Northern Ireland drug tariffs The first of Dexcom's scan-free and finger prick-free † devices available on prescription for people with Type 1 diabetes an...
The middle of June marked a turning point for the stock market and new leadership has emerged for the recent run-up, according to Credit Suisse. Driving returns have been stocks that are Speculative (high correlation to Bitcoin ( BTC-USD )), Expensive (high P/E), Beaten Down (52...
With another round of quarterly results stirring trading in Friday's midday action, Chevron ( NYSE: CVX ) and Five9 ( FIVN ) both received buying interest following the release of strong earnings reports. Elsewhere, DexCom ( DXCM ) had the opposite reaction to its quarte...
Shares of DexCom (NASDAQ: DXCM) were falling 5.2% lower as of 11:15 a.m. ET on Friday after sinking as much as 10.9% earlier in the day. The decline came after the diabetes-care technology company announced its second-quarter financial results after the market close on Thursday. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 10:00:00 ET Growth-oriented investors have experienced a bit of a roller-coaster ride over the past few years. Many companies in the "growth stock" category were struggling just two years ago, but in the bull market we are now experiencing, they're delivering very different resul...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the...